Checkpoint modulation in chronic hepatitis B: From hypothesis to approval

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatology (Baltimore, Md.) Md.), 2018-03, Vol.67 (3), p.1175-1176
Hauptverfasser:	Germanidis, Georgios, Hytiroglou, Prodromos, Vassiliadis, Themistoklis, Speletas, Matthaios
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Agents Drug Approval Hepatitis B Hepatitis B, Chronic Hepatology Humans
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	1176
container_issue	3
container_start_page	1175
container_title	Hepatology (Baltimore, Md.)
container_volume	67
creator	Germanidis, Georgios Hytiroglou, Prodromos Vassiliadis, Themistoklis Speletas, Matthaios
description
doi_str_mv	10.1002/hep.29695
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1971667836</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2007993004</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3485-99f87fecc5ba8eb887db66d8b00e142c1dd9f132c9d2bfb5452f67dcde3fff753</originalsourceid><addsrcrecordid>eNp1kMtKw0AUQAdRbK0u_AEJuNFF2nlkMjPutLRWKOhC10MyD5KaZGImUfr3jra6EFxduBzOvRwAzhGcIgjxrDDtFItU0AMwRhSzmBAKD8EYYgZjgYgYgRPvNxBCkWB-DEZYIJGknI7Bw7ww6rV1ZdNHtdNDlfWla6KyiVTRuaZUUZCHXV_66O4mWnaujopt6_rC-LDqXZS1befes-oUHNms8uZsPyfgZbl4nq_i9eP9w_x2HSuScBoLYTmzRimaZ9zknDOdp6nmOYQGJVghrYVFBCuhcW5zmlBsU6aVNsRayyiZgKudN5x9G4zvZV16Zaoqa4wbvESCoTRlnKQBvfyDbtzQNeE7iSFkQhAIk0Bd7yjVOe87Y2XblXXWbSWC8quvDAnkd9_AXuyNQ14b_Uv-BA3AbAd8lJXZ_m-Sq8XTTvkJ7jSEzw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2007993004</pqid></control><display><type>article</type><title>Checkpoint modulation in chronic hepatitis B: From hypothesis to approval</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Germanidis, Georgios ; Hytiroglou, Prodromos ; Vassiliadis, Themistoklis ; Speletas, Matthaios</creator><creatorcontrib>Germanidis, Georgios ; Hytiroglou, Prodromos ; Vassiliadis, Themistoklis ; Speletas, Matthaios</creatorcontrib><identifier>ISSN: 0270-9139</identifier><identifier>EISSN: 1527-3350</identifier><identifier>DOI: 10.1002/hep.29695</identifier><identifier>PMID: 29194685</identifier><language>eng</language><publisher>United States: Wolters Kluwer Health, Inc</publisher><subject>Antiviral Agents ; Drug Approval ; Hepatitis B ; Hepatitis B, Chronic ; Hepatology ; Humans</subject><ispartof>Hepatology (Baltimore, Md.), 2018-03, Vol.67 (3), p.1175-1176</ispartof><rights>2017 by the American Association for the Study of Liver Diseases.</rights><rights>2018 by the American Association for the Study of Liver Diseases.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3485-99f87fecc5ba8eb887db66d8b00e142c1dd9f132c9d2bfb5452f67dcde3fff753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhep.29695$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhep.29695$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,778,782,1414,27907,27908,45557,45558</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29194685$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Germanidis, Georgios</creatorcontrib><creatorcontrib>Hytiroglou, Prodromos</creatorcontrib><creatorcontrib>Vassiliadis, Themistoklis</creatorcontrib><creatorcontrib>Speletas, Matthaios</creatorcontrib><title>Checkpoint modulation in chronic hepatitis B: From hypothesis to approval</title><title>Hepatology (Baltimore, Md.)</title><addtitle>Hepatology</addtitle><subject>Antiviral Agents</subject><subject>Drug Approval</subject><subject>Hepatitis B</subject><subject>Hepatitis B, Chronic</subject><subject>Hepatology</subject><subject>Humans</subject><issn>0270-9139</issn><issn>1527-3350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtKw0AUQAdRbK0u_AEJuNFF2nlkMjPutLRWKOhC10MyD5KaZGImUfr3jra6EFxduBzOvRwAzhGcIgjxrDDtFItU0AMwRhSzmBAKD8EYYgZjgYgYgRPvNxBCkWB-DEZYIJGknI7Bw7ww6rV1ZdNHtdNDlfWla6KyiVTRuaZUUZCHXV_66O4mWnaujopt6_rC-LDqXZS1befes-oUHNms8uZsPyfgZbl4nq_i9eP9w_x2HSuScBoLYTmzRimaZ9zknDOdp6nmOYQGJVghrYVFBCuhcW5zmlBsU6aVNsRayyiZgKudN5x9G4zvZV16Zaoqa4wbvESCoTRlnKQBvfyDbtzQNeE7iSFkQhAIk0Bd7yjVOe87Y2XblXXWbSWC8quvDAnkd9_AXuyNQ14b_Uv-BA3AbAd8lJXZ_m-Sq8XTTvkJ7jSEzw</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Germanidis, Georgios</creator><creator>Hytiroglou, Prodromos</creator><creator>Vassiliadis, Themistoklis</creator><creator>Speletas, Matthaios</creator><general>Wolters Kluwer Health, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201803</creationdate><title>Checkpoint modulation in chronic hepatitis B: From hypothesis to approval</title><author>Germanidis, Georgios ; Hytiroglou, Prodromos ; Vassiliadis, Themistoklis ; Speletas, Matthaios</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3485-99f87fecc5ba8eb887db66d8b00e142c1dd9f132c9d2bfb5452f67dcde3fff753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antiviral Agents</topic><topic>Drug Approval</topic><topic>Hepatitis B</topic><topic>Hepatitis B, Chronic</topic><topic>Hepatology</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Germanidis, Georgios</creatorcontrib><creatorcontrib>Hytiroglou, Prodromos</creatorcontrib><creatorcontrib>Vassiliadis, Themistoklis</creatorcontrib><creatorcontrib>Speletas, Matthaios</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Hepatology (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Germanidis, Georgios</au><au>Hytiroglou, Prodromos</au><au>Vassiliadis, Themistoklis</au><au>Speletas, Matthaios</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Checkpoint modulation in chronic hepatitis B: From hypothesis to approval</atitle><jtitle>Hepatology (Baltimore, Md.)</jtitle><addtitle>Hepatology</addtitle><date>2018-03</date><risdate>2018</risdate><volume>67</volume><issue>3</issue><spage>1175</spage><epage>1176</epage><pages>1175-1176</pages><issn>0270-9139</issn><eissn>1527-3350</eissn><cop>United States</cop><pub>Wolters Kluwer Health, Inc</pub><pmid>29194685</pmid><doi>10.1002/hep.29695</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0270-9139
ispartof	Hepatology (Baltimore, Md.), 2018-03, Vol.67 (3), p.1175-1176
issn	0270-9139 1527-3350
language	eng
recordid	cdi_proquest_miscellaneous_1971667836
source	MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects	Antiviral Agents Drug Approval Hepatitis B Hepatitis B, Chronic Hepatology Humans
title	Checkpoint modulation in chronic hepatitis B: From hypothesis to approval
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T10%3A14%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Checkpoint%20modulation%20in%20chronic%20hepatitis%20B:%20From%20hypothesis%20to%20approval&rft.jtitle=Hepatology%20(Baltimore,%20Md.)&rft.au=Germanidis,%20Georgios&rft.date=2018-03&rft.volume=67&rft.issue=3&rft.spage=1175&rft.epage=1176&rft.pages=1175-1176&rft.issn=0270-9139&rft.eissn=1527-3350&rft_id=info:doi/10.1002/hep.29695&rft_dat=%3Cproquest_cross%3E2007993004%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2007993004&rft_id=info:pmid/29194685&rfr_iscdi=true